↗1 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$831KSold on the market
1Companies
Oct 7, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 202616:00 | Oct 5, 2026 | AMLXAmylyx Pharmaceuticals, Inc. | Director | S · Sell10b5-1 | $27.70 | −30,000 | 782,881 | -4% | −$831K |